Modus Therapeutics Stock Forward View - Triple Exponential Smoothing
| MODTX Stock | 0.31 0.02 6.90% |
This page provides reference data for Modus Therapeutics using Triple Exponential Smoothing forecasting. The projected value and error metrics are calculated from available daily price observations.
The Triple Exponential Smoothing forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.31 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.68.As with simple exponential smoothing, in triple exponential smoothing models past Modus Therapeutics observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Modus Therapeutics Holding observations. This Triple Exponential Smoothing reference page for Modus Therapeutics presents model-generated projections from historical price data for informational purposes. Triple Exponential Smoothing Price Forecast For the 22nd of March
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Modus Therapeutics Holding on the next trading day is expected to be 0.31 with a mean absolute deviation of 0.01 , mean absolute percentage error of 0.0003 , and the sum of the absolute errors of 0.68 .Please note that although there have been many attempts to predict Modus Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Modus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Modus Therapeutics | Modus Therapeutics Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Modus Therapeutics Holding uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. The current forecast range spans downside near 0.0031 and upside near 5.16.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Modus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Modus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0029 |
| MAD | Mean absolute deviation | 0.0114 |
| MAPE | Mean absolute percentage error | 0.037 |
| SAE | Sum of the absolute errors | 0.6844 |
Other Forecasting Options for Modus Therapeutics
For investors considering Modus, Modus Therapeutics' price movement is the most direct driver of investment returns. Noise in Modus Stock price charts can make identifying meaningful trends difficult without dedicated analytical tools.Modus Therapeutics Related Equities
The following equities are related to Modus Therapeutics within the Biotechnology space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Modus Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Modus Therapeutics Market Strength Events
Market strength indicators for Modus Therapeutics provide investors with a view of how the stock performs across different market environments. By analyzing these indicators, traders can determine the best moments to enter or exit positions in Modus Therapeutics Holding.
| Accumulation Distribution | 2586.39 | |||
| Daily Balance Of Power | 1.0 | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 0.3 | |||
| Day Typical Price | 0.3 | |||
| Price Action Indicator | 0.02 | |||
| Period Momentum Indicator | 0.02 |
Modus Therapeutics Risk Indicators
A structured analysis of Modus Therapeutics' risk indicators is one of the most reliable ways to improve the accuracy of price forecasts. Understanding the risk embedded in Modus Therapeutics' allows investors to decide whether to accept, reduce, or hedge their exposure.
| Mean Deviation | 3.19 | |||
| Standard Deviation | 4.69 | |||
| Variance | 21.97 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Modus Therapeutics
Story coverage around Modus Therapeutics Holding often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Modus Therapeutics Short Properties
Short-interest signals around Modus Therapeutics Holding can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 12.4 M | |
| Cash And Short Term Investments | 20.6 M |
Additional Tools for Modus Stock Analysis
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |